eHealth (EHTH): Shares move into bullish "pennant", on good earnings

So many things are sold on the Web now that it can be difficult to remember when it all got started. Some might be surprised to know, for example, that the first Internet-based sale of a U.S. health insurance policy was made over ten years ago. The firm involved was a Mountain View, California outfit that serves nearly 400,000 customers today.

eHealth, Inc. (NASDAQ: EHTH) is an online source of health insurance for individuals, families and small businesses. The company presents health insurance information in a user-friendly format, enabling the comparison and purchase of health insurance products that best meet consumers' needs. The firm is licensed throughout the United States, operating in partnership with some 160 health insurance carriers. It provides health, dental, and vision insurance products from the likes of Aetna Inc. (NYSE: AET), Cigna Corporation (NYSE: CI) and Coventry Health Care, Inc. (NYSE: CVH).

eHealth pleased investors earlier in the month, when it reported 3rd Quarter (Q3) earnings per share (EPS) of 15 cents and revenues of $23 million. Analysts had been expecting 12 cents and $22.4 million. Management also guided fiscal year (FY) 2007 EPS to 51-55 cents (48 cent consensus) and FY07 revenues to $87.2-$88.0 million ($86.8M consensus). Estimated membership grew 35%year over year. EHTH shares popped on the news and then moved into a bullish "pennant" consolidation pattern. Prices frequently exit pennants moving in the same direction they were traveling on entry. In this case, that would be to the upside.

Brokers recommend the issue with four "strong buys", three "holds" and a "sell". Analysts see a 32% growth rate, through the next year. The EHTH Sales Growth rate (37.72%), Net Profit Margin (25.05%), Return on Assets (27.98%), Return on Investment (32.14%) and Return on Equity (103.02%) compare favorably with industry, sector and S&P 500 averages. Institutional investors hold about 67 percent of the outstanding shares. Over the past 52 weeks, the stock has traded between $17.67 and $34.89. A stop-loss of $28.70 if one were to consider the stock looks good here.

Larry Schutts is a contributing editor for Theflyonthewall.com and the Vice-President of Stockwinners.com.